Scientific Highlights

January

Microbial burden is a biomarker of fecal microbiota transplant response in patients with Crohn’s disease

View the news in the media Redacción Médica

February

The DISCOvERIE project, led by Vall d’Hebron, will provide an enhanced understanding on IBS and comorbidities and the risk factors

View the news in the media La Vanguardia

March

Vall d’Hebron participates in an international study that completes the largest genetic map of psychiatric disorders so far

View the news in the media La Vanguardia

Vall d’Hebron participates in an international position statement on the use of antihypertensive drugs in COVID-19 patients

Vall d’Hebron participates in two clinical trials against the coronavirus using Remdesivir

View the news in the media Beteve

Vall d’Hebron enrolled the first patient in Catalonia in an international clinical trial with sarilumab in patients with severe COVID-19

View the news in the media CCMA

Vall d’Hebron researchers have sequenced the SARS-CoV-2 virus genome of two patients

View the news in the media TV3

April

Achieved intracellular release of antibodies to block SMC2 against tumor stem cells

Vall d’Hebron participates in a clinical trial with vafidemstat to avoid serious respiratory complications in patients with COVID-19

View the news in the media La Sexta

Vall d’Hebron participates in a clinical trial to evaluate the efficacy and safety of low-dose selinexor in patients with severe COVID-19

View the news in the media La Vanguardia

Identified two miRNAs capable of stopping the progression of rhabdomyosarcoma

Vall d’Hebron shows that there is a shared genetic basis between ADHD in childhood and adulthood

View the news in the media Infosalus

May

Demonstrated the oncogenic role of the Aurora Borealis protein in ovarian cancer

Multidisciplinary research opens the door to the development of new therapeutic approaches in Parkinson’s disease

View the news in the media Infosalus

A study by Vall d’Hebron shows that rheumatic patients treated with immunomodulatory therapies do not have an increased risk of COVID-19 infection

June

Identified a new pathway to attack tumor cells

View the news in the media 20 Minutos

Vall d’Hebron participates in a pioneering study that classifies skin conditions in patients with COVID-19

Vall d’Hebron researchers find a possible strategy for SARS-CoV-2 to strengthen its persistence in the host and facilitate its transmission

View the news in the media La Vanguardia

Vall d’Hebron researchers describe a preeclampsia-like syndrome in pregnancies with COVID-19

View the news in the media TV3

Genes may cause some people to develop severe forms of COVID-19

View the news in the media El País

The eye as a window to the brain. The European project RECOGNISED will determine the usefulness of the retina as a tool for identifying type 2 diabetes and cognitive impairment

July

A Vall d’Hebron study shows that 70% of residents and 56% of staff infected with SARS-CoV-2 in nursing homes are asymptomatic

View the news in the media Beteve

August

A 13-year study by Vall d’Hebron shows that community actions improve access to diagnosis and treatment of Chagas disease in Barcelona

View the news in the media El Punt Avui

Vall d’Hebron describes two cases of fetuses with edema in pregnant women with COVID-19

View the news in the media Catalunya Ràdio

A study by Vall d’Hebron shows that patients with severe pulmonary injury due to COVID-19 have increased risk of stroke

View the news in the media TV3

A study by Vall d’Hebron concludes that transmission of SARS-CoV-2 from minors with COVID-19 to adults with whom they live is low

View the news in the media Beteve

September

Vall d’Hebron identifies a key protein to prevent breast cancer metastases

View the news in the media Ara

Vall d’Hebron demonstrate negative effects of lockdown in patients with epilepsy

View the news in the media Beteve

15% of severe cases of COVID-19 would have genetic and immunological factors, according to two international studies with the participation of Vall d’Hebron

View the news in the media El Punt Avui

October

Vall d’Hebron shows that ECMO can save the life of the most severe COVID-19 patients

View the news in the media Diario Médico

A new artificial intelligence tool will help detect whether a liver is useful for transplantation

View the news in the media El País

November

A study by Vall d’Hebron shows that headache could indicate a better clinical course of COVID-19

View the news in the media La Vanguardia

Vall d’Hebron identifies biomarkers that would detect women at higher risk of breast cancer

View the news in the media TVE

Asthma could protect against COVID-19 in a specific group of asthmatic patients

View the news in the media El Periódico

December

The antitumor drug ABTL0812 shows promising results against neuroblastoma

View the news in the media ABC

Vall d’Hebron suggests that the immune system through a cytotoxic attack of T lymphocytes would cause Parkinson’s disease

View the news in the media La Vanguardia

Vall d’Hebron begins clinical trial of Janssen’s COVID-19 vaccine

View the news in the media ConSalud